Dantrolene, a therapeutic agent for malignant hyperthermia, markedly improves the function of failing cardiomyocytes by stabilizing inter-domain interactions within the ryanodine receptor

OBJECTIVES: To investigate the effect of dantrolene, a drug generally used to treat Malignant Hyperthermia (MH), on the Ca(2+) release and cardiomyocyte function in failing hearts. BACKGROUND: The N-terminal (N: 1-600) and Central (C: 2000-2500) domains of the ryanodine receptor (RyR), harbor many m...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Kobayashi, Shigeki, Yano, Masafumi, Suetomi, Takeshi, Ono, Makoto, Tateishi, Hiroki, Mochizuki, Mamoru, Xu, Xiaojuan, Uchinoumi, Hitoshi, Okuda, Shinichi, Yamamoto, Takeshi, Koseki, Noritaka, Kyushiki, Hiroyuki, Ikemoto, Noriaki, Matsuzaki, Masunori
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2009
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2764410/
https://ncbi.nlm.nih.gov/pubmed/19460614
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacc.2009.01.065
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak